Relay Therapeutics
Megan Bonney is a seasoned scientist with extensive experience in molecular biology and oncology. Currently serving as a Principal Scientist at Relay Therapeutics since February 2019, Megan has progressed through various roles at the company, including Senior Scientist positions. Prior to Relay Therapeutics, Megan was a Postdoctoral Fellow in Oncology at Novartis Institutes for BioMedical Research, where significant contributions were made in designing reporter cell lines and investigating transcription factor mutations in cancer. Education includes a Ph.D. in Molecular Biology from the Massachusetts Institute of Technology and a Bachelor's Degree in Biology from Haverford College. Early research experience involved studying cancer mechanisms and molecular properties in various academic and research settings.
This person is not in any teams
This person is not in any offices
Relay Therapeutics
2 followers
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology.